RecruitingNot ApplicableNCT05902871

Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population

Direct Selective Laser Trabeculoplasty for Primary Open Angle Glaucoma and Ocular Hypertension and Normal Tension Glaucoma in Ethnic Chinese Population - The Zhuiguangzhe Trial


Sponsor

BelkinVision

Enrollment

45 participants

Start Date

Mar 11, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this study is to evaluate the safety and effectiveness of Direct Selective Laser Trabeculoplasty (DSLT) in ethnic Chinese participants with Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT), or Normal Tension Glaucoma (NTG).


Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating the effectiveness of selective laser trabeculoplasty (SLT) — a laser procedure that helps fluid drain from the eye to lower pressure — as a first-line treatment in Chinese patients with glaucoma or elevated eye pressure. **You may be eligible if...** - You are of Chinese ethnicity with corrected vision better than 6/18 in both eyes - You have been diagnosed with mild to moderate open-angle glaucoma, ocular hypertension, or normal tension glaucoma - You are willing to attend follow-ups over 12 months and follow study procedures **You may NOT be eligible if...** - You have had prior surgery on the study eye - You are pregnant or may become pregnant during the study - You work in a vision-critical profession (e.g., pilot or commercial driver) - You are unable to perform a reliable visual field test - You have certain eye conditions or are taking certain medications as specified in the protocol Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEExternal Automatic Glaucoma Laser

Trans-limbal, direct selective laser trabeculoplasty (DSLT) instrument that directs laser energy through the sclera around the limbus overlying the trabecular meshwork and treats 360 degrees of the angle is treated simultaneously

PROCEDUREDirect Selective Laser Trabeculoplasty

Surgical procedure that utilizes a laser to improve fluid drainage in the eye and reduce intraocular pressure


Locations(2)

C-Mer Eye Clinic

Hong Kong, China

SERI

Singapore, Singapore

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05902871


Related Trials